Showing 4401-4410 of 6036 results for "".
- iHealthScreen Announces FDA 510(k) Submission for iPredict Automated AI-Based AMD Toolhttps://modernod.com/news/ihealthscreen-announces-fda-510k-submission-for-ipredict-automated-ai-based-amd-tool/2481632/iHealthScreen has submitted for FDA 510(k) clearance for iPredict, making it the first company to apply for an FDA clearance for screening AMD, according to a company news release. iPredict AI Eye Screening System provides fully automated age-related macular degener
- Partnership Agreement Between Mireca and Graybug Terminatedhttps://modernod.com/news/partnership-agreement-between-mireca-and-graybug-terminated/2481631/Mireca Medicines announced that the partnership agreement between Mireca and Graybug (now CalciMedica) has been terminated due to a shift in drug development focus of CalciMedica away from ocular diseases. As part of the termination, all intellectual property rights that
- FDA Approves Bausch + Lomb and Novaliq's Miebo for the Treatment of the Signs and Symptoms of Dry Eye Diseasehttps://modernod.com/news/bausch-lomb-and-novaliq-announce-fda-approval-of-miebotm-perfluorohexyloctane-ophthalmic-solution-for-the-treatment-of-the-signs-and-symptoms-of-dry-eye-disease/2481625/Bausch + Lomb announced on Thursday that the FDA has approved Miebo (perfluorohexyloctane ophthalmic solution; formerly known as NOV03) for the treatment of the signs and symptoms of dry eye disease (DED). The comapnies say Miebo is the first and only FDA-approved treatment fo
- International Sports Vision Association Launches "Ask a Sports Vision Expert" Featurehttps://modernod.com/news/international-sports-vision-association-launches-ask-a-sports-vision-expert-feature/2481622/A growing body of evidence confirms that visual abilities can be strengthened and enhanced by means of appropriate visual training. Sports vision, the science of helping athletes reach peak levels of performance through enhancement of visual skills, is becoming more important in training for all
- Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapieshttps://modernod.com/news/ray-therapeutics-closes-oversubscribed-100m-series-a-financing-to-advance-optogenetic-gene-therapies/2481621/Ray Therapeutics announced an upsized and oversubscribed $100 million Series A financing round to advance multiple programs targeting blinding diseases through clinical development. Ray Therapeutics has developed an optogenetic platform to bioengineer a pipeline of g
- Invirsa Completes Enrollment of Phase 1/2a Dry Eye Studyhttps://modernod.com/news/invirsa-completes-enrollment-of-phase-12a-dry-eye-study/2481619/Invirsa announced that its first clinical trial, a phase 1/2a study with the primary objective to determine safety and preliminary efficacy of Invirsa's topically administered eye drop formulation of INV-102, has completed enrollment. Subjects had moderate dry eye and dosing was well tol
- C. Light Receives FDA Clearance for Retinal Eye Movement Monitor, Retitrackhttps://modernod.com/news/c-light-receives-fda-clearance-for-retinal-eye-movement-monitor-retitrack/2481615/C. Light Technologies announced it has received 510(k) clearence from the FDA for the Retitrack, which is designed to provide new understanding and insight into oculomotor function via the retina, providing concrete and objective metrics to medical professionals. The
- Oculus Incorporates New Subsidiary in Indiahttps://modernod.com/news/oculus-incorporates-new-subsidiary-in-india/2481614/Oculus has incorporated Oculus Medical Devices India as its 12th international subsidiary as of May 1, 2023. Located in Mumbai, Oculus India, aims to provide cutting-edge medical equipment to the Indian market while maintaining the high standards and quality that Oculus is known for. Sr
- New Museum of the Eye Exhibit Explores the Eye as a Cultural Symbol, From Ancient to Modern Timeshttps://modernod.com/news/new-museum-of-the-eye-exhibit-explores-the-eye-as-a-cultural-symbol-from-ancient-to-modern-times/2481612/Truhlsen-Marmor Museum of the Eye, the world’s only free, public museum dedicated to the science of sight, announced the opening of "Decoding the Eye: Signs and Symbols," a new exhibit exploring how the eye appears as a symbol throughout time. The exhibit will run from May 2023 to
- Eyenovia Receives FDA Approval of Mydcombi, the First Ophthalmic Spray for Mydriasishttps://modernod.com/news/eyenovia-receives-fda-approval-of-mydcombi-the-first-ophthalmic-spray-for-mydriasis/2481603/Eyenovia announced that the FDA has approved Mydcombi (tropicamide and phenylephrine hydrochloride ophthalmic spray) 1%/2.5% for inducing mydriasis for diagnostic procedures and in conditions where short term pupil dilation is desired. This represents the first approved fixed dose combinatio